Global Automated Breast Ultrasound System Market
Automated Breast Ultrasound System (ABUS) is an innovative breast cancer screening device. ABUS technology uses high-frequency sound waves to diagnose the cancers and provides the 3-D image of the breasts. It is mainly used to diagnose breast cancer conditions in dense breasts, where breasts have more glandular tissue than fatty tissue.
Increase in demand for radiation-free, non-invasive technologies and less diagnosis time are expected to fuel the growth of the market revenue for automated breast ultrasound system over the forecast period. Furthermore, a rise in prevalence of breast cancers and their related deaths are driving the market during the forecast period. According to World Cancer Research Fund International, in 2012, it is estimated that nearly 1.5 new million cases are diagnosed with breast cancer. The highest number of breast cancers incidences are observed in North America and Oceania. Among all the cancers, 12% of cancers are breast cancers and it is one of the leading cause of cancer-related deaths in women. However, lack of skilled professionals and awareness about the automated breast ultrasound system market are hindering the growth of the market over the forecast period.
Global Automated Breast Ultrasound System Market segmented on the basis of product type, modality, and end user
Based on the product type, global Automated Breast Ultrasound System Market segmented into as follows:
- Automated Breast Ultrasound System (ABUS)
- Automated Breast Volume Scanner (ABVS)
Based on modality, global Automated Breast Ultrasound System Market segmented into as follows:
Based on end users, global Automated Breast Ultrasound System Market has been segmented into the following:
- Ambulatory Surgical Centers
- Diagnostic Centers
Automated Breast Ultrasound System Market is still in nascent stage. Very few players are actively involved in the development of automated breast ultrasound system market. However, it gained traction from investors to develop automated breast ultrasound system owing to its benefits such as high sensitivity, 3-D imaging system, and portable in nature. Lack of sensitivity of mammography in identifying breast cancers in dense breasts creating opportunities for automated ultrasound system market. Automated breast ultrasound system can detect cancers in small, early stage in dense breast tissues when it is combined with mammography and increase in adoption in hospitals are expected to propel the market over the forecast period. Bigger players are actively involved in collaboration and acquisition of start-ups to strengthen its product portfolio in automated breast ultrasound system market. For instance, in September 2012, the U.S. FDA approved first automated breast ultrasound system developed by U-Systems Inc., acquired by GE Healthcare.
Geographically market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America expected to have larger market share owing to favourable reimbursement policies and recent product launches in the region are boosting the market revenue over the forecast period. For instance, from January 2015, Indiana state passed a law for women with dense breasts. New CPT codes 76641 and 76642 are introduced for ultrasound examination of breasts to replace code 76645. These both codes represent complete and focused ultrasound examination of the breasts. Asia-Pacific region is expected to grow at a significant CAGR owing to the large pool of population and rise in breast cancer population. Companies are launching automated breast ultrasound systems market into Asia-Pacific market to expand their geographical footprints. In February 2010, in India, Siemens Healthcare GmbH introduced automated breast volume scanner (ABVS) at Jaslok Hospital and Research Center.
Global Automated Breast Ultrasound System Market dominated by key players such as Hitachi, Ltd., Siemens Healthcare GmbH, SonoCiné, General Electric Company, Toshiba Medical Systems Corporation, and Koninklijke Philips N.V. In June 2014, the U.S. FDA approved General Electric Healthcare’s, Invenia automated breast ultrasound system, a next-generation breast imaging technology to diagnose the breast cancers in dense breasts.
- In September 2015, GE Healthcare and Symed L.L.C team launched Automated Breast Ultrasound system (ABUS) in Dubai
- In February 2014, Philips Healthcare entered distribution agreement with SonoCine to market its automated whole breast ultrasound (AWBUS) system in the U.S. market
- The report provides granular level information about the market size, regional market share, and forecast from 2017-2023
- The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
- The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments, and startup’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework, and reimbursement scenario